Rockwell Automation (ROK) Could Be 5% Undervalued After Cell Therapy Platform Win

Rockwell Automation (ROK) just saw its FactoryTalk software and Process Library embedded into PBS Biotech's MiniPRO bioreactor platform, tying the industrial automation specialist directly into cell therapy process development workflows. Rockwell Automation’s recent client wins and leadership changes arrive as the share price trades at US$455.18, with a 7 day share price return of 5.56% and year to date share price gain of 14.21%. The 1 year total shareholder return of 32.33% points to...